Noom is a psychology-based weight-loss program that pairs behavior-change lessons with human coaches and AI support — and, for those who qualify, GLP-1 medication through Noom Med.
Noom’s premise is that diets fail because they never address the “why” behind eating habits. Instead of macros or banned food groups, the core program is built on daily interactive psychology lessons about behavioral change, a color-coded food-logging system (green/yellow/red foods), and a human coach plus cutting-edge AI support inside the app. The goal isn’t just weight loss but sustained results: a 2023 Obesity Science & Practice study found 75% of Noom participants kept at least 5% of weight off after a year.
Noom has since expanded into medication. Noom Med offers access to weight-loss medication — including GLP-1s like Ozempic, Wegovy, and Mounjaro, plus a compounded GLP-1Rx program — with a GLP-1 Companion designed to build sustainable habits alongside the drugs. Noom claims 37% more weight loss with Noom + GLP-1 than medication alone. A preventive health program and enterprise offerings for employers and health plans extend the platform beyond weight loss.
The honest caveats: pricing varies by promotion and region, and user reviews frequently flag aggressive upsells and painful cancellation/refund experiences — check the checkout price carefully and cancel at least 24 hours before renewal.
7-day trial, then a subscription: monthly plan $70/month, annual plan $209/year (about $17.42/month), with intermediate plans in between. Noom Med GLP-1Rx starts around $149 for the initial 3-week subscription plus $349/month thereafter (prices per noom.com, effective March 2026). Check checkout for current promotions.
Ideal for people who have failed at diet apps before and need psychology, coaching, and accountability rather than another calorie counter. Less suitable for budget users (premium calorie trackers cost far less) or anyone wanting clinical obesity care without app engagement.